Perrigo Company Plc
Could not find a ticker for this position, may be a filing error
A maker of over-the-counter self-care products, Perrigo supplies store-brand medicines to retailers and also sells its own brands like Opill®, Mederma®, Compeed®, and Solpadeine® across North America and Europe. The company traces back to 1887, when Michigan general-store owner Luther Perrigo began packaging medicines and household goods for other country stores — and pioneered the private-label idea by printing each store's own name on the labels. The company still bears his name today.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 13G/APassive | 6.3% | 8.70M | Aug 14, 2026 |
| BlackRock, Inc. | 13G/APassive | 15.2% | 20.99M | Jul 29, 2026 |
| Vanguard Portfolio Management | 13GPassive | 5.99% | 8.25M | Apr 28, 2026 |
| Vanguard Capital Management | 13GPassive | 5.27% | 7.26M | Apr 28, 2026 |
| Dimensional Fund Advisors LP | 13G/APassive | 4.8% | 6.57M | Apr 9, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| Fuller & Thaler Asset Management, Inc. | 13GPassive | 5.69% | 7.82M | Feb 17, 2026 |
| Neuberger Berman Group LLC | 13GPassive | 5.5% | 7.54M | Feb 5, 2026 |
| Neuberger Berman Investment Advisers LLC | 13GPassive | 5.5% | 7.52M | Feb 5, 2026 |
| STATE STREET CORPORATION | 13GPassive | 5.3% | 7.34M | Aug 11, 2025 |